Serology-based therapeutic strategy in SARS-CoV-2-infected patients-Reference-Cited by-同舟云学术

Serology-based therapeutic strategy in SARS-CoV-2-infected patients

Published:2021-12 Issue: Volume:101 Page:108214
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Garcia-Muñoz Ricardo,Farfán-Quiroga Giovanna,Ruiz-de-Lobera Noemí,Feliu Jesus,Anton-Remirez Judith,Nájera Irazu Maria José,Lisa Catón Valentín,Oteo-Revuelta José Antonio

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference21 articles.

1. Recovery collaborative group. Dexamethasone in hospitalized patients with COVID19- preliminary report;Horby;N Engl. J. Med.,2020

2. National Institutes of Health. The COVID-19 Treatment Guidelines Paneĺs Statement on the emergency use authorization of convalescent plasma for the treatment of covid-19. Accessed at www.covid19treatmentguidelines.nih.gov/statement-on-convalescent-plasma-eua on 7 September 2020.

3. C. Salvarani, G. Dolci, M.D. Masari, et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID19 Pneumonia. A Randomized Clinical Trial. JAMA Intern Med. 181(1) (2021) 24–31. Doi:10.1001/jamaintermed.2020.6615.

4. A. Bhimraj, R.L. Morgan, A.H. Shumaker, et al, Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID19. Infections Diseases Society of America 2021. Version 4.3.0. Available at https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/.

5. Antibody therapies for the prevention and treatment of viral infections;Salazar;NPJ Vacc.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?;Drug Design, Development and Therapy;2022-03